Protocol: PK Bridging ELISA For Use With Anti-Palivizumab Antibodies
Pharmacokinetic (PK) Bridging ELISA: For use with anti-palivizumab monoclonal antibody products HCA261 and HCA262P
This method provides a procedure for carrying out a PK ELISA with anti-palivizumab antibodies, product codes HCA261 (capture antibody) and HCA262P (detection antibody), and using palivizumab monoclonal antibody for the standard curve.
The method should always be used in conjunction with product and batch specific information provided with each vial (see product datasheets). This protocol will need to be adjusted for use with different detection methods and immunoassay technology platforms.
View all of our palivizumab antibodies
MaxiSorp™ and QuantaBlu™ are trademarks of Thermo Fisher Scientific.
Tween® is a registered trademark of ICI Americas Inc.